VEXAS syndrome is a recently described monogenic autoinflammatory disease capable of manifesting itself with a wide array of organs and tissues involvement. Orbital/ocular inflammatory manifestations are frequently described in VEXAS patients. The objective of this study is to further describe orbital/ocular conditions in VEXAS syndrome while investigating potential associations with other disease manifestations. In the present study, twenty-seven out of 59 (45.8 %) VEXAS patients showed an inflammatory orbital/ocular involvement during their clinical history. The most frequent orbital/ocular affections were represented by periorbital edema in 8 (13.6 %) cases, episcleritis in 5 (8.5 %) patients, scleritis in 5 (8.5 %) cases, uveitis in 4 (6.8 %) cases, conjunctivitis in 4 (6.8 %) cases, blepharitis in 3 (5.1 %) cases, orbital myositis in 2 (3.4 %) cases. A diagnosis of systemic immune-mediated disease was observed in 15 (55.6 %) cases, with relapsing polychondritis diagnosed in 12 patients. A significant association was observed between relapsing polychondritis and orbital/ocular involvement in VEXAS syndrome (Relative Risk: 2.37, 95 % C.I. 1.03–5.46, p = 0.048). Six deaths were observed in the whole cohort of patients after a median disease duration of 1.2 (IQR=5.35) years, 5 (83.3 %) of which showed orbital/ocular inflammatory involvement. In conclusion, this study confirms that orbital/ocular inflammatory involvement is a common finding in VEXAS patients, especially when relapsing polychondritis is diagnosed. This makes ophthalmologists a key figure in the diagnostic process of VEXAS syndrome. The high frequency of deaths observed in this study seems to suggest that patients with orbital/ocular involvement may require increased attention and more careful follow-up.

Orbital/ocular inflammatory involvement in VEXAS syndrome: Data from the international AIDA network VEXAS registry / Vitale, A.; Caggiano, V.; Martin-Nares, E.; Frassi, M.; Dagna, L.; Hissaria, P.; Sfriso, P.; Hernandez-Rodriguez, J.; Ruiz-Irastorza, G.; Monti, S.; Tufan, A.; Piga, M.; Giardini, H. A. M.; Lopalco, G.; Viapiana, O.; De Paulis, A.; Triggianese, P.; Vitetta, R.; de-la-Torre, A.; Fonollosa, A.; Caroni, F.; Sota, J.; Conticini, E.; Sbalchiero, J.; Renieri, A.; Casamassima, G.; Wiesik-Szewczyk, E.; Yildirim, D.; Hinojosa-Azaola, A.; Crisafulli, F.; Franceschini, F.; Campochiaro, C.; Tomelleri, A.; Callisto, A.; Beecher, M.; Bindoli, S.; Baggio, C.; Gomez-Caverzaschi, V.; Pelegrin, L.; Soto-Peleteiro, A.; Milanesi, A.; Vasi, I.; Cauli, A.; Antonelli, I. P. D. B.; Iannone, F.; Bixio, R.; Casa, F. D.; Mormile, I.; Gurnari, C.; Fiorenza, A.; Mejia-Salgado, G.; Kawakami-Campos, P. A.; Ragab, G.; Ciccia, F.; Ruscitti, P.; Bocchia, M.; Balistreri, A.; Tosi, G. M.; Frediani, B.; Cantarini, L.; Fabiani, C.. - In: SEMINARS IN ARTHRITIS AND RHEUMATISM. - ISSN 0049-0172. - 66:(2024). [10.1016/j.semarthrit.2024.152430]

Orbital/ocular inflammatory involvement in VEXAS syndrome: Data from the international AIDA network VEXAS registry

De Paulis A.;Triggianese P.;Mormile I.;
2024

Abstract

VEXAS syndrome is a recently described monogenic autoinflammatory disease capable of manifesting itself with a wide array of organs and tissues involvement. Orbital/ocular inflammatory manifestations are frequently described in VEXAS patients. The objective of this study is to further describe orbital/ocular conditions in VEXAS syndrome while investigating potential associations with other disease manifestations. In the present study, twenty-seven out of 59 (45.8 %) VEXAS patients showed an inflammatory orbital/ocular involvement during their clinical history. The most frequent orbital/ocular affections were represented by periorbital edema in 8 (13.6 %) cases, episcleritis in 5 (8.5 %) patients, scleritis in 5 (8.5 %) cases, uveitis in 4 (6.8 %) cases, conjunctivitis in 4 (6.8 %) cases, blepharitis in 3 (5.1 %) cases, orbital myositis in 2 (3.4 %) cases. A diagnosis of systemic immune-mediated disease was observed in 15 (55.6 %) cases, with relapsing polychondritis diagnosed in 12 patients. A significant association was observed between relapsing polychondritis and orbital/ocular involvement in VEXAS syndrome (Relative Risk: 2.37, 95 % C.I. 1.03–5.46, p = 0.048). Six deaths were observed in the whole cohort of patients after a median disease duration of 1.2 (IQR=5.35) years, 5 (83.3 %) of which showed orbital/ocular inflammatory involvement. In conclusion, this study confirms that orbital/ocular inflammatory involvement is a common finding in VEXAS patients, especially when relapsing polychondritis is diagnosed. This makes ophthalmologists a key figure in the diagnostic process of VEXAS syndrome. The high frequency of deaths observed in this study seems to suggest that patients with orbital/ocular involvement may require increased attention and more careful follow-up.
2024
Orbital/ocular inflammatory involvement in VEXAS syndrome: Data from the international AIDA network VEXAS registry / Vitale, A.; Caggiano, V.; Martin-Nares, E.; Frassi, M.; Dagna, L.; Hissaria, P.; Sfriso, P.; Hernandez-Rodriguez, J.; Ruiz-Irastorza, G.; Monti, S.; Tufan, A.; Piga, M.; Giardini, H. A. M.; Lopalco, G.; Viapiana, O.; De Paulis, A.; Triggianese, P.; Vitetta, R.; de-la-Torre, A.; Fonollosa, A.; Caroni, F.; Sota, J.; Conticini, E.; Sbalchiero, J.; Renieri, A.; Casamassima, G.; Wiesik-Szewczyk, E.; Yildirim, D.; Hinojosa-Azaola, A.; Crisafulli, F.; Franceschini, F.; Campochiaro, C.; Tomelleri, A.; Callisto, A.; Beecher, M.; Bindoli, S.; Baggio, C.; Gomez-Caverzaschi, V.; Pelegrin, L.; Soto-Peleteiro, A.; Milanesi, A.; Vasi, I.; Cauli, A.; Antonelli, I. P. D. B.; Iannone, F.; Bixio, R.; Casa, F. D.; Mormile, I.; Gurnari, C.; Fiorenza, A.; Mejia-Salgado, G.; Kawakami-Campos, P. A.; Ragab, G.; Ciccia, F.; Ruscitti, P.; Bocchia, M.; Balistreri, A.; Tosi, G. M.; Frediani, B.; Cantarini, L.; Fabiani, C.. - In: SEMINARS IN ARTHRITIS AND RHEUMATISM. - ISSN 0049-0172. - 66:(2024). [10.1016/j.semarthrit.2024.152430]
File in questo prodotto:
File Dimensione Formato  
1-s2.0-S0049017224000702-main.pdf

accesso aperto

Tipologia: Versione Editoriale (PDF)
Licenza: Dominio pubblico
Dimensione 1.72 MB
Formato Adobe PDF
1.72 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/958806
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? ND
social impact